Fungal pathogens kill roughly 2.5 million people each year and cause an estimated 6.5 million invasive infections globally, yet they receive a fraction of the research funding devoted to bacteria and viruses.1PubMed. Global incidence and mortality of severe fungal disease That gap between impact and attention is closing, driven by hospital outbreaks of drug-resistant species, climate change reshuffling where pathogenic fungi can thrive, and a pandemic that left millions of people with weakened lungs vulnerable to secondary fungal infections. The story of fungal pathogens stretches well beyond human medicine, though, reaching into agriculture, wildlife conservation, and even the basic question of why mammals evolved warm blood in the first place.
Why Warm Blood Keeps Most Fungi at Bay
Of the millions of known fungal species, only a few hundred regularly infect humans. The main reason is temperature. Most fungi grow well at ambient environmental temperatures but struggle above about 35°C. Research modeling the tradeoff between metabolic cost and thermal defense found that mammalian body temperature sits at an almost mathematically optimal point: 36.7°C, the temperature that maximizes protection from fungal colonization relative to the energy required to maintain it.2PubMed Central. Mammalian endothermy optimally restricts fungi and metabolic costs In practical terms, every 1°C increase in the range between 30°C and 40°C excludes an additional 6% of fungal isolates, which also helps explain why fever works as a defense: cranking body temperature a few degrees higher expands the thermal exclusion zone even further.3The Journal of Infectious Diseases. Vertebrate Endothermy Restricts Most Fungi as Potential Pathogens
This thermal barrier is good news for healthy people but bad news for anyone whose immune system is compromised. The few fungal species that can tolerate 37°C are the ones that cause nearly all human disease, and when the immune system falters, even those relatively limited species can be devastating. That dynamic explains why invasive fungal infections cluster so heavily among people with HIV, organ transplant recipients on immunosuppressive drugs, cancer patients receiving chemotherapy, and people in intensive care units.
Climate Change Is Redrawing the Map
Warming temperatures are not just an abstract concern for fungi. Rising heat may be pushing some environmental fungi to adapt to higher temperatures, potentially narrowing the thermal gap that protects mammals.4PubMed Central. Global warming will bring new fungal diseases for mammals At the same time, changing climate patterns are already expanding the geographic range of well-known fungal diseases. Valley fever, caused by the soil fungus Coccidioides, has historically been concentrated in the hot, arid southwestern United States. Modeling suggests that by 2100 under a high-warming scenario, the endemic area for Valley fever could more than double, the number of affected U.S. states could rise from 12 to 17, and annual cases could increase by about 50%, with the fungus spreading northward into states like Idaho, Wyoming, and Montana.5PubMed Central. Expansion of Coccidioidomycosis Endemic Regions in the United States in Response to Climate Change
Valley fever is not the only disease on the move. Histoplasmosis and blastomycosis, two other soil-dwelling fungal infections that were once considered regional problems of the Ohio and Mississippi River valleys, are being diagnosed in areas where they were previously rare.6PubMed. Climate Change and Medical Mycology Altered precipitation patterns play a role too: drought-then-rain cycles can aerosolize fungal spores more effectively, and flooding can redistribute contaminated soil. Doctors in newly affected areas may not immediately think of fungal infection when a patient presents with persistent cough and fatigue, which can delay diagnosis and treatment.
Candida auris and Hospital-Acquired Infections
If climate change represents a slow-moving threat, Candida auris is a fast one. First identified in 2009, this yeast species has spread across healthcare systems on every inhabited continent and now ranks among the most alarming hospital-acquired infections. It resists multiple classes of antifungal drugs, persists on surfaces and skin for weeks, and spreads readily between patients in intensive care settings.7PubMed Central. The rising challenge of Candida auris: insights into its transmission, drug resistance, and infection control strategies Outbreaks have been sustained by a combination of the fungus’s tenacity on hospital surfaces, prolonged colonization of patients’ skin, and the intense antimicrobial pressure typical of ICU environments. The COVID-19 pandemic amplified the problem, as overwhelmed hospital systems had less capacity for the aggressive infection-control measures C. auris demands.8PubMed. Candidozyma auris (formerly Candida auris): resistant, long lasting, and everywhere
Part of what makes C. auris so difficult to handle is that standard hospital disinfectants sometimes fail to eliminate it, and conventional diagnostic tests can misidentify it as a different Candida species. When it does cause bloodstream infections, mortality rates are high, partly because treatment options are limited by the organism’s resistance profile.
Where Drug Resistance Comes From
The antifungal drug arsenal has always been smaller than the antibacterial one, largely because fungi are eukaryotic cells, biochemically much closer to human cells than bacteria are. That similarity makes it harder to find drug targets that hurt the fungus without also harming the patient. Only a handful of antifungal drug classes exist, and resistance to some of them is growing.
One surprising driver of resistance comes from agriculture. Azole fungicides are sprayed widely on crops and used in the wood industry, and they share the same mechanism of action as the azole drugs used in hospitals. Fungi like Aspergillus fumigatus can develop resistance to agricultural azoles in the environment and then infect a human host who has never taken an antifungal drug, arriving pre-resistant to the most commonly prescribed treatment. The same cross-resistance phenomenon has been observed in Candida and Cryptococcus species.9PLoS Pathogens. Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond This agricultural-medical pipeline is one of the more uncomfortable realities in infectious disease: practices that protect food crops may simultaneously be eroding the drugs used to protect people.
How Fungi Breach Their Hosts
Fungal pathogens use a range of strategies to invade tissue, some of them remarkably physical. The rice blast fungus Magnaporthe oryzae, which threatens rice harvests around the world, builds a specialized infection cell called an appressorium. This cell generates extraordinary internal pressure and uses it to drive a rigid peg straight through the tough outer layer of a rice leaf, punching through the plant’s defenses by brute force.10PubMed Central. A molecular mechanosensor for real-time visualization of appressorium membrane tension in Magnaporthe oryzae The pressures involved are far greater than anything measured in other cell types, a mechanical feat that researchers have described as extreme even by biological standards.11bioRxiv. Direct measurement of appressorium turgor using a molecular mechanosensor in the rice blast fungus Magnaporthe oryzae
Human-infecting fungi use subtler tricks. Candida albicans, the most common cause of yeast infections and a major cause of hospital-acquired bloodstream infections, can switch between a round yeast form and elongated filamentous threads called hyphae. This shapeshifting is central to its ability to cause disease: the filamentous form can penetrate tissue, escape immune cells that have swallowed it, and help the fungus colonize new sites in the body.12PubMed Central. From Jekyll to Hyde: The Yeast-Hyphal Transition of Candida albicans Many pathogenic fungi also form biofilms, structured communities that coat medical devices like catheters and prosthetic joints. Biofilms are a major cause of recurrent infections because they are far less susceptible to antifungal drugs than free-floating cells.13PubMed Central. Fungal biofilms, drug resistance, and recurrent infection
The Immune System’s Fungal Radar
Your immune system detects fungi in part by recognizing a sugar molecule called beta-glucan, a major structural component of most fungal cell walls. Immune cells such as macrophages and dendritic cells carry a surface receptor called Dectin-1 that binds to beta-glucan, triggering both an immediate defensive response and signaling that helps coordinate longer-term immune activity.14PubMed Central. Beta-glucan recognition by the innate immune system The Dectin-1 system performs double duty: it pulls fungal particles into the immune cell for destruction and simultaneously sends signals that ramp up inflammation and recruit reinforcements.15PubMed Central. Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1
This detection system has become medically useful in its own right. Blood tests that measure circulating beta-glucan levels are now used to help diagnose invasive fungal infections, and recognizing what triggers Dectin-1 has informed research into antifungal vaccines. The same pathway has even been explored as a way to boost immune function in cancer therapy, since activating beta-glucan receptors can enhance the body’s broader immune surveillance.
Fungi, Pandemics, and Secondary Infections
Severe viral respiratory infections create conditions that are almost ideal for fungal invasion of the lungs. Influenza has long been recognized as a risk factor for invasive pulmonary aspergillosis, a potentially lethal lung infection caused by Aspergillus molds. COVID-19 brought the same pattern at massive scale: patients on ventilators, receiving steroids and other immunosuppressive treatments, developed fungal co-infections at alarming rates.16PubMed Central. Pathogenesis of Respiratory Viral and Fungal Coinfections The combination of viral lung damage, immune suppression from treatment, and prolonged ICU stays created a perfect storm. In India, a surge of mucormycosis cases during COVID-19 waves drew global attention, though Aspergillus remained the more common fungal complication worldwide.
Diagnosing these co-infections remains difficult. Traditional culture-based methods are slow, and fungi can be hard to grow from respiratory samples. Newer molecular tools, including specialized PCR assays and next-generation sequencing, are improving turnaround times, but they are not yet widely available in all settings.17PubMed Central. Diagnosis of invasive fungal infections: challenges and recent developments The gap between when a patient becomes infected and when the infection is confirmed can be the difference between recovery and death.
Threats Beyond Human Health
Some of the most dramatic consequences of fungal pathogens are playing out in wildlife and agriculture. The chytrid fungus Batrachochytrium dendrobatidis has driven catastrophic declines in amphibian populations worldwide. It attacks the skin, which amphibians rely on for breathing and regulating water and salts. In diseased frogs, electrolyte transport across the skin drops by more than half, blood sodium falls by roughly 20%, and potassium drops by about 50%, ultimately causing cardiac arrest.18PubMed. Pathogenesis of chytridiomycosis, a cause of catastrophic amphibian declines Hundreds of species have been affected, and several have gone extinct.
In North American bats, white-nose syndrome has killed millions of hibernating animals since it was first detected around 2006. The causative fungus, Pseudogymnoascus destructans, grows on the skin of bats during hibernation, when their body temperatures drop low enough for the fungus to thrive. Infected bats wake from torpor far too often, burning through their fat reserves before winter ends. Research has shown that infected bats have both higher metabolic rates during torpor and greater rates of water loss compared to healthy controls, suggesting two independent pathways draining their energy.19PubMed Central. White-nose syndrome increases torpid metabolic rate and evaporative water loss in hibernating bats
On the agricultural side, Fusarium wilt is threatening the global banana supply. A strain called Tropical Race 4 attacks Cavendish bananas, which account for over 90% of all banana exports.20PLoS Pathogens. Multi-site fungicides suppress banana Panama disease, caused by Fusarium oxysporum f. sp. cubense Tropical Race 4 This is eerily reminiscent of the mid-twentieth century, when an earlier strain of Fusarium wiped out the Gros Michel variety that dominated world trade, forcing the entire industry to shift to the resistant Cavendish. Now the Cavendish itself is vulnerable, and Tropical Race 4 has spread from Southeast Asia to the Middle East, Africa, and South America.21PubMed Central. Fusarium Wilt of Banana: Current Knowledge on Epidemiology and Research Needs Toward Sustainable Disease Management No widely adopted resistant replacement variety exists yet.
Mycotoxins and the Food Supply
Not all fungal damage requires a living infection. Some fungi produce toxic chemical byproducts called mycotoxins that contaminate food during crop growth, harvest, or storage. The most consequential is aflatoxin B1, produced by Aspergillus species that colonize staple crops like maize, peanuts, and tree nuts. Aflatoxin B1 is classified as one of the most potent naturally occurring carcinogens and is strongly linked to liver cancer.22PubMed. Aflatoxin B1: metabolism, toxicology, and its involvement in oxidative stress and cancer development After ingestion, liver enzymes convert aflatoxin B1 into a highly reactive molecule that binds directly to DNA, causing mutations in genes that normally suppress tumor growth.23PubMed. Aflatoxin B1 and food safety: Mechanisms of action associated to Hepatocellular Carcinoma
Aflatoxin contamination is a far bigger problem in tropical and subtropical regions, where warm, humid conditions favor Aspergillus growth and where grain storage infrastructure may be limited. Regulatory testing catches most contaminated batches in high-income countries, but chronic low-level exposure remains a significant public health concern in parts of sub-Saharan Africa and South Asia, where it compounds the liver damage caused by hepatitis B virus and contributes to some of the world’s highest rates of liver cancer.
New Drugs and the Race Against Resistance
For decades, doctors relied on just three main classes of antifungal drugs. The newest additions to the pipeline aim to hit different targets. Echinocandins, the most recently established class, work by blocking an enzyme that builds beta-glucan in the fungal cell wall. Without that structural sugar, the wall weakens and the fungus dies from osmotic stress.24PubMed Central. Echinocandins – structure, mechanism of action and use in antifungal therapy Several next-generation drugs are in development that work through entirely new mechanisms, including compounds that target fungal enzymes with no equivalent in human cells, a design principle that should reduce side effects.25PubMed Central. The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Whether these new drugs arrive fast enough to keep pace with resistance is an open question. The agricultural azole problem described earlier is not going away, and the rise of C. auris shows how quickly multi-drug resistance can emerge and spread in a clinical setting. Antifungal stewardship, the practice of using these drugs judiciously to slow the evolution of resistance, is gaining attention but lags far behind the equivalent effort for antibiotics.
Your Body’s Fungal Residents
Not every fungus living in your body is causing harm. The human gut and skin harbor a resident community of fungi collectively called the mycobiota, and in healthy people, this community coexists peacefully with bacterial neighbors and the immune system. Disruption of that balance, known as fungal dysbiosis, is increasingly recognized as a factor in disease. Shifts in the mycobiota can alter immune signaling and have been linked to inflammatory conditions affecting the gut and other mucosal surfaces.26PubMed Central. Fungal dysbiosis: immunity and interactions at mucosal barriers Broad-spectrum antibiotics are one of the most common triggers, since wiping out competing bacteria can give fungi room to overgrow. Anyone who has developed a yeast infection after a course of antibiotics has experienced this dynamic firsthand.
Research into the mycobiota is still young compared to the explosion of work on bacterial gut communities. But the emerging picture suggests that fungal and bacterial residents interact constantly, and that ignoring the fungal side of the microbiome gives an incomplete view of how the body’s internal ecosystem shapes health.
Zombie Ants and Behavioral Hijacking
Among the stranger chapters in fungal biology is the genus Ophiocordyceps, a group of parasitic fungi that infect insects and manipulate their behavior with unsettling precision. The best-studied species target carpenter ants. After infection, the fungus grows through the ant’s body and eventually compels it to leave the colony, climb vegetation, and clamp its jaws onto a leaf or twig in a specific position favorable for fungal spore dispersal. The ant dies in this “death grip,” and the fungus erupts from its body to release spores onto the forest floor below, where they can infect the next passing ant.27PubMed Central. Species-specific ant brain manipulation by a specialized fungal parasite
The specificity is remarkable: different Ophiocordyceps species manipulate different ant species, and a fungus adapted to one ant host often cannot successfully manipulate another, even a closely related one. How the fungus orchestrates such precise behavioral control remains an active area of research, with evidence pointing to the secretion of compounds that interact with the ant’s nervous system. The phenomenon has no direct medical relevance, but it illustrates the extraordinary evolutionary versatility of fungal pathogens and how deeply they can integrate with a host’s biology.
Ergot and the Long Shadow of Fungal History
Fungal pathogens have shaped human history in ways that were not understood at the time. The ergot fungus, Claviceps purpurea, infects cereal grains like rye and produces alkaloid toxins that, when consumed in contaminated bread, cause a condition called ergotism. Symptoms ranged from burning sensations in the limbs and gangrene to convulsions and hallucinations, depending on which alkaloids predominated.28PubMed Central. Ergot: from witchcraft to biotechnology Epidemics of ergotism swept through medieval Europe repeatedly, sometimes killing thousands. The convulsive form of ergotism, with its hallucinations and bizarre behavior, has been proposed as a contributing factor in episodes of mass hysteria, including some witch trials, though historians debate how central it was versus social and political forces.
In an ironic twist, the same alkaloids that caused so much suffering became the basis for important pharmaceuticals. Ergotamine derivatives are still used to treat migraines, and the discovery of lysergic acid diethylamide (LSD) by Albert Hofmann in 1943 began with his work on ergot alkaloids. The Claviceps story captures something essential about fungal pathogens as a whole: they are biochemically inventive organisms whose chemical products can be simultaneously devastating and medically useful, depending entirely on context and dose.